Navigating perimenopause often brings a range of changes, and for many women, hot flashes are a significant experience. These sudden sensations of heat can be disruptive, and many individuals seek ways to support their well-being during this transition.
This article explores the current understanding of how magnesium, specifically magnesium glycinate, might relate to hot flashes during perimenopause. We will review the available research to provide an evidence-based perspective on this topic.
Understanding Hot Flashes in Perimenopause
Hot flashes, also known as vasomotor symptoms, are a common characteristic of perimenopause and menopause. They are often described as a sudden feeling of warmth that spreads over the body, sometimes accompanied by sweating and flushing. While the exact mechanisms are complex, they are thought to be related to fluctuating hormone levels, particularly estrogen, which can affect the body’s thermoregulatory center [1].
The frequency and intensity of hot flashes can vary significantly among individuals, impacting daily life and sleep quality. Many women explore various approaches to manage these symptoms during this transitional phase [2].
Magnesium’s Role in Body Function
Magnesium is an essential mineral involved in over 300 biochemical reactions in the body. It plays a role in muscle and nerve function, blood glucose management, blood pressure regulation, and the structural development of bone. It is also necessary for energy production [3].
Given its broad involvement in physiological processes, researchers have explored magnesium’s potential influence on various health aspects, including those related to perimenopause and menopause. Magnesium glycinate is a form of magnesium that is often chosen for its bioavailability and gentle effect on the digestive system.
Magnesium and Hot Flashes: What the Research Suggests
Magnesium has been tested for hot flashes, and the honest summary is that the one properly controlled trial was negative. Both studies below were run in menopausal women with a history of breast cancer rather than in perimenopausal women generally, so read them with that limitation in mind as well.
An early pilot phase II trial gave magnesium oxide to breast cancer patients with frequent hot flashes; 25 of the 29 enrolled completed treatment, and weekly hot flash frequency fell by 41.4 percent [4]. It matters what that study was and was not. It had no placebo arm and no control group, every participant knew she was taking magnesium, and hot flashes respond strongly to placebo. Its own authors said as much, closing with the note that a randomized placebo-controlled trial was planned.
That trial was run, and it did not confirm the pilot. The North Central Cancer Treatment Group N10C2 (Alliance) study enrolled 289 women and randomized them, double-blind, to magnesium oxide 800 mg daily, magnesium oxide 1,200 mg daily, or matching placebo. Mean hot flash scores, mean hot flash frequencies, and their changes over the treatment period were similar in every group. The authors’ own conclusion is that the results do not support the use of magnesium oxide for hot flashes [5]. The magnesium arms also reported an increased incidence of diarrhea compared with placebo.
Both studies enrolled women who had experienced breast cancer, whose hot flashes may differ from those of perimenopause in the general population, and no trial has tested magnesium for hot flashes in perimenopausal women without a cancer history [2]. That is a real gap. But it would be misleading to describe the picture as simply thin: in the one population where magnesium has been properly tested against placebo for this symptom, it did not outperform placebo.
Why Magnesium Glycinate?
Magnesium glycinate is a chelated form of magnesium, meaning magnesium is bound to the amino acid glycine. This binding is thought to enhance absorption and reduce the likelihood of digestive upset, which can sometimes be associated with other forms of magnesium [3].
No published study has tested magnesium glycinate specifically for hot flashes; a PubMed search for the pairing returns nothing at all. Glycinate is a common choice because it is easy on the stomach and easy to take daily, not because it has been shown to do anything for vasomotor symptoms.
Considering Magnesium for Perimenopause
Calling this evidence “still developing” would overstate it. The glycinate form has never been tested for hot flashes, and the parent mineral failed the one placebo-controlled test it was given. What remains true is narrower, and worth keeping: magnesium is involved in a wide range of physiological processes and adequate intake matters at any life stage, including perimenopause [3]. That is a reason to avoid deficiency, not a reason to expect relief from hot flashes.
Many women in perimenopause explore various dietary and lifestyle adjustments to support their comfort. Ensuring sufficient magnesium intake through diet or supplementation could be one aspect of a broader wellness strategy. However, it is important to approach such considerations with realistic expectations, especially given the limited direct evidence for hot flashes in this specific context.
Safety and Considerations
Magnesium is generally well-tolerated, but high doses can lead to gastrointestinal upset, such as diarrhea [3], and this is not hypothetical at the doses used for hot flashes, since N10C2 recorded more diarrhea on 800 to 1,200 mg of magnesium daily than on placebo [5]. Magnesium glycinate is often chosen in the hope of a gentler digestive profile, though no trial has compared it head-to-head against other forms on that outcome.
Individuals with kidney conditions or those taking certain medications should exercise caution and consult with a healthcare professional before starting any magnesium supplement. It is always advisable to discuss any new supplement with a healthcare provider to ensure it is appropriate for your individual health needs.
References
- How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel Review. Journal of personalized medicine, 2024
- Integrative approaches to perimenopause. The American journal of medicine, 2026
- A review of select vitamins and minerals used by postmenopausal women. Maturitas, 2010
- A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011
- North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause (New York, N.Y.), 2015
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
